文献速递生殖医学产科

左甲状腺素对甲状腺自身免疫女性妊娠结局的影响:随机对照试验的系统综述与Meta分析

Effect of levothyroxine on pregnancy outcomes in women with thyroid autoimmunity: a systematic review with meta-analysis of randomized controlled trials.
PubMed 文献 · Fertil Steril · 2020-09-08

该系统综述与Meta分析纳入甲状腺过氧化物酶抗体阳性女性,评估左甲状腺素是否改善活产及其他妊娠结局。结果显示左甲状腺素补充与活产率增加或流产风险降低无关,亚组分析结果相似;中至高质量证据表明左甲状腺素未改善临床妊娠结局。

要点

  • 左甲状腺素补充与活产率增加无关,与流产风险降低也无关。
  • 按年龄、基线促甲状腺激素、基线甲状腺过氧化物酶抗体、体重指数及辅助受孕使用情况分层的活产亚组分析结果相似。
  • 中至高质量证据表明,甲状腺过氧化物酶抗体阳性女性使用左甲状腺素未改善临床妊娠结局。

核心结论

  • 中至高质量证据表明,甲状腺过氧化物酶抗体阳性女性使用左甲状腺素与临床妊娠结局改善无关。
  • 左甲状腺素补充与活产率增加或流产风险降低均无关。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、Embase和Cochrane对照试验中心注册库,无语言限制,采用随机效应模型计算合并效应量。
  • 研究对象为甲状腺过氧化物酶抗体阳性女性。
  • 主要结局包括活产、流产、早产、临床妊娠、异位妊娠、新生儿入院和出生体重,汇总指标以相对危险度(RR)及95%置信区间报告。
  • 注册号:PROSPERO CRD42019132976。

主要发现

  • 左甲状腺素补充与活产率增加无关,与流产风险降低也无关。
  • 按年龄、基线促甲状腺激素、基线甲状腺过氧化物酶抗体、体重指数及辅助受孕使用情况分层的活产亚组分析结果相似。
  • 对于活产,效应估计值位于RR为20%和15%的无效边界内,但在RR为10%时,效应估计值位于无效边界与劣效边界之间。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate whether levothyroxine is associated with improved live birth and other benefits in women with thyroid autoimmunity. DESIGN: Systematic review and meta-analysis. SETTING: Not applicable. PATIENT(S): Women positive for thyroid peroxidase antibody. INTERVENTION(S): MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were searched without any language restrictions. Pooled effect sizes were calculated using random-effects models. MAIN OUTCOME MEASURE(S): The primary outcome was the incidence of live birth, miscarriage, preterm birth, clinical pregnancy, ectopic pregnancy, neonatal admission, and birth weight. The summary measures were reported as relative risk (RR) with 95% confidence interval. RESULT(S): Levothyroxine supplementation was not associated with an increased rate of live birth or a decreased risk of miscarriage. Results were similar in subgroup analyses of live birth by age, baseline thyrotropin, baseline thyroid peroxidase antibody, body mass index, and use of assisted conception. For live birth, the effect estimate lay within the futility boundary for RR of 20% and 15%, but at a 10% RR, the effect estimate lay between the futility boundary and the inferior boundary. CONCLUSION(S): High- to moderate-quality evidence demonstrated that the use of levothyroxine was not associated with improvements in clinical pregnancy outcomes among women positive for thyroid peroxidase antibody. REGISTRATION NUMBER: PROSPERO CRD42019132976.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Wang X, Zhang Y, Tan H, et al. Effect of levothyroxine on pregnancy outcomes in women with thyroid autoimmunity: a systematic review with meta-analysis of randomized controlled trials. Fertil Steril. 2020. PMID: 32912635. doi:10.1016/j.fertnstert.2020.06.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。